Burton GW, Traber MG, Acuff RV, et al. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E.
Am J Clin Nutr.
1998;67:669 - 684.
Traber MG, Elsner A, Brigelius-Flohe R. Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates.
FEBS Lett.
1998;437:145 - 148.
Institute of Medicine
. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids.
National Academy Press, 2000.
Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.
J Natl Cancer Inst. 2000;92:2018 - 2023.
Christen S, Woodall AA, Shigenaga MK, et al. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications.
Proc Natl Acad Sci U S A. 1997;94:3217 - 3222.
Kiyose C, Muramatsu R, Kameyama Y, et al. Biodiscrimination of alpha-tocopherol stereoisomers in humans after oral administration.
Am J Clin Nutr. 1997;65:785 - 789.
Burton GW, Traber MG, Acuff RV, et al. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E.
Am J Clin Nutr.
1998;67:669 - 684.
Hercberg S, Preziosi P, Galan P, et al. Vitamin status of a healthy French population: dietary intakes and biochemical markers.
Int J Vitam NutrRes. 1994;64:220 - 232.
Murphy SP, Subar AF, Block G. Vitamin E intakes and sources in the United States.
Am J Clin Nutr. 1990;52:361 - 367.
Ford ES, Sowell A. Serum alpha-tocopherol status in the United States population: findings from the Third National Health and Nutrition Examination study.
Am J Epidemiol.
1999;150:290 - 300.
West RJ, Lloyd JK. The effect of cholestyramine on intestinal absorption.
Gut. 1975;16:93-98.
Zheng W, Sellers TA, Doyle TJ, et al. Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women.
Am J Epidemiol.
1995;142:955 - 960.
Esteve J, Riboli E, Pequignot G, et al. Diet and cancers of the larynx and hypopharynx: the IARC multi-center study in southwestern Europe.
Cancer Causes Control
1996;7:240 - 252.
Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study.
Am J Clin Nutr. 1995;62(suppl):1427S - 1430S.
Chen J, Geissler C, Parpia B, et al. Antioxidant status and cancer mortality in China.
Int J Epidemiol.
1992;21:625 - 635.
White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer.
Cancer Epidemiol Biomarkers Prev. 1997;6:769 - 774.
Macready N. Vitamins associated with lower colon-cancer risk.
Lancet.
1997;350:9089.
Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly.
Am J Clin Nutr. 1996;64:190 - 196.
Bostick RM, Potter JD, McKenzie DR, et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study.
Cancer Res.
1993;53:4230 - 4237.
Ocke MC, Bueno-de-Mesquita H, Feskens EJ, et al. Repeated measurements of vegetables, fruits, beta-carotene, and vitamins C and E in relation to lung cancer. The Zutphen Study.
Am J Epidemiol.
1997;145:358 - 365.
Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.
Ann Intern Med.
1998;129:517 - 524.
Malila N, Virtamo J, Virtanen M, et al. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers.
Cancer Epidemiol Biomarkers Prev.
1999;8:489 - 493.
Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
N Engl J Med.
1996;334:1145 - 1149.
Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group.
N Engl J Med.
1994;331:141 - 147.
Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.
JNatl Cancer Inst. 1998;90:440 - 446.
Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta-carotene on the incidence of angina pectoris.
JAMA.
1996;275:693 - 698.
Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
N Engl J Med.
2000;342:154 - 160.
Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice.
Lancet. 2001;357:89 - 95.
Adler LA, Edson R, Lavori P, et al. Long-term treatment effects of vitamin E for tardive dyskinesia.
Biol Psychiatry. 1998;43:868 - 872.
Lohr JB, Caligiuri MP. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
J Clin Psychiatry. 1996;57:167 - 173.
Rotrosen J, Adler L, Lohr J, et al. Antioxidant treatment of tardive dyskinesia.
Prostaglandins Leukot Essent Fatty Acids. 1996;55:77 - 81.
Adler LA, Peselow E, Rotrosen J, et al. Vitamin E treatment of tardive dyskinesia.
Am J Psychiatry. 1993;150:1405 - 1407.
Sajjad SH. Vitamin E in the treatment of tardive dyskinesia: a preliminary study over 7 months at different doses.
Int Clin Psychopharmacol. 1998;13:147 - 155.
Fuchs J, Kern H. Modulation of UV-light-induced skin inflammation by d-alpha-tocopherol and l-ascorbic acid: a clinical study using solar simulated radiation.
Free Radic Biol Med.
1998;25:1006 - 1012.
Eberlein-Konig B, Placzek M, and Przybilla B. Protective effect against sunburn of combined systemic ascorbic acid (vitamin C) and d-alpha-tocopherol (vitamin E).
J Am Acad Dermatol.
1998;38:45 - 48.
Darr D, Dunston S, Faust H, et al. Effectiveness of antioxidants (vitamin C and E) with and without sunscreens as topical photoprotectants.
Acta Derm Venereol. 1996;76:264 - 268.
Trevithick JR, Shum DT, Redae S, et al. Reduction of sunburn damage to skin by topical application of vitamin E acetate following exposure to ultraviolet B radiation: effect of delaying application or of reducing concentration of vitamin E acetate applied.
Scanning Microsc. 1993;7:1269 - 1281.
Trevithick JR, Xiong H, Lee S, et al. Topical tocopherol acetate reduces post-UVB, sunburn-associated erythema, edema, and skin sensitivity in hairless mice.
Arch Biochem Biophys. 1992;296:575 - 582.
van Rooij J, Schwartzenberg SGWS, Mulder PGH, et al. Oral vitamins C and E as additional treatment in patients with acute anterior uveitis: a randomised double masked study in 145 patients.
Br J Ophthalmol.
1999;83:1277 - 1282.
Manzella D, Barbieri M, Ragno E, et al. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes.
Am J Clin Nutr. 2001;73:1052 - 1057.
Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial.
Lancet.
1999;354:810 - 816.
Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.
JAMA. 1997;277:1380 - 1386.
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease.
N Engl J Med. 1997;336:1216 - 1222.
Edmonds SE, Winyard PG, Guo R, et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial.
Ann Rheum Dis.
1997;56:649 - 655.
Knekt P, Heliovaara M, Aho K, et al. Serum selenium, serum alpha-tocopherol, and the risk of rheumatoid arthritis [abstract].
Epidemiology.
2000;11:402 - 405.
Tutuncu NB, Baraktar M, Varli K. Reversal of defective nerve conduction with vitamin E supplementation in type 2 diabetes.
Diabetes Care.
1998;21:1915 - 1918.
Kahler W, Kuklinski B, Ruhlmann C, et al. Diabetes mellitus - a free radical-associated disease. Results of adjuvant antioxidant supplementation [in German; English abstract].
Z Gesamte Inn Med.
1993;48:223 - 232.
Bursell SE, Clermont AC, Aiello LP, et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes.
Diabetes Care.
1999;22:1245 - 1251.
Suleiman SA, Ali ME, Zaki ZM, et al. Lipid peroxidation and human sperm motility: protective role of vitamin E.
J Androl. 1996;17:530 - 537.
Rolf C, Cooper TG, Yeung CH, et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study.
Hum Reprod.
1999;14:1028 - 1033.
Tavani A, Negri E, La Vecchia C. Food and nutrient intake and risk of cataract.
Ann Epidemiol. 1996;6:41 - 46.
Leske MC, Chylack LT Jr, He Q, et al. Antioxidant vitamins and nuclear opacities: the longitudinal study of cataract.
Ophthalmology. 1998;105:831 - 836.
Teikari JM, Rautalahti M, Haukka J, et al. Incidence of cataract operations in Finnish male smokers unaffected by alpha tocopherol or beta carotene supplements.
J Epidemiol Community Health. 1998;52:468 - 472.
Seddon JM, Christen WG, Manson JE, et al. The use of vitamin supplements and the risk of cataract among US male physicians.
Am J Public Health. 1994;84:788 - 792.
Paolisso G, D'Amore A, Galzerano D, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients.
Diabetes Care. 1993;16:1433 - 1437.
Paolisso G, Di Maro G, Galzerano D, et al. Pharmacological doses of vitamin E and insulin action in elderly subjects.
Am J Clin Nutr. 1994;59:1291 - 1296.
Paolisso G, D'Amore A, Giugliano D, et al. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients.
Am J Clin Nutr. 1993;57:650 - 656.
McAlindon TE, Jacques P, Zhang Y, et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?
Arthritis Rheum. 1996;39:648 - 656.
Ayres S, Mihan R. Restless legs syndrome: response to vitamin E.
J Appl Nutr.
1973;25:8 - 15.
Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.
Neurology.
2000;54:1265 - 1272.
London RS, Murphy L, Kitlowski KE, et al. Efficacy of alpha-tocopherol in the treatment of the premenstrual syndrome.
J Reprod Med. 1987;32:400 - 404.
London RS, Sundaram GS, Murphy L, et al. The effect of alpha-tocopherol on premenstrual symptomatology: a double-blind study.
J Am Coll Nutr. 1983;2:115 - 122.
McBride JM, Kraemer WJ, Triplett-McBride T, et al. Effect of resistance exercise on free radical production.
Med Sci Sports Exerc.
1998;30:67 - 72.
Craig BW. The effects of vitamin E supplementation on the oxidative and mechanical stresses associated with an acute bout of resistance training. Presented at: The Integrative Biology of Exercise; September 20-23, 2000; Portland, Me. 2000.
Buchman AL, Killip D, Ou C-N, et al. Short-term vitamin E supplementation before marathon running: a placebo-controlled trial.
Nutrition. 1999;15:278 - 283.
Kachel DL, Moyer TP, Martin WJ II. Amiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherol.
J Pharmacol Exp Ther. 1990;254:1107 - 1112.
Abrams B, Duncan D, Hertz-Picciotto I. A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men.
J Acquir Immune Defic Syndr. 1993;6:949 - 958.
Allard JP, Aghdassi E, Chau J, et al. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects.
AIDS. 1998;12:1653 - 1659.
Gogu SR, Beckman BS, Rangan SR, et al. Increased therapeutic efficacy of zidovudine in combination with vitamin E.
Biochem Biophys ResCommun. 1989;165:401 - 407.
London RS, Sundaram GS, Murphy L, et al. The effect of vitamin E on mammary dysplasia: a double-blind study.
Obstet Gynecol. 1985;65:104 - 106.
The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.
New Engl J Med.
1993;97:176 - 183.
Kieburtz K, McDermott M, Como P, et al. The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study Group.
Neurology.
1994;44:1756 - 1759.
Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa.
Ann Neurol.
1996;39:37 - 45.
Barton DL, Loprinzi CL, Quella SK, et al. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
J Clin Oncol.
1998;16:495 - 500.
Tornwall ME, Virtamo J, Haukka JK, et al. The effect of alpha-tocopherol and beta-carotene supplementation on symptoms and progression of intermittent claudication in a controlled trial.
Atherosclerosis.
1999;147:193 - 197.
Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.
J Natl Cancer Inst. 1998;90:440 - 446.
Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study.
Am J Clin Nutr.
1995;62(Suppl):S1427 - S1430.
Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris.
JAMA. 1996;275:693 - 698.
Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.
JNatl Cancer Inst.
1998;90:440 - 446.
Keith ME, Jeejeebhoy KN, Langer A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure.
Am J Clin Nutr. 2001;73:219 - 224.
Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.
JNatl Cancer Inst. 1998;90:440 - 446.
Helzlsouer KJ, Huang HY, Alberg AJ, et al. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer.
J Natl Cancer Inst. 2000;92:2018 - 2023.
Zheng W, Sellers TA, Doyle TJ, et al. Retinol, antioxidant vitamins, and cancers of the upper digestive tract in a prospective cohort study of postmenopausal women.
Am J Epidemiol.
1995;142:955 - 960.
Esteve J, Riboli E, Pequignot G, et al. Diet and cancers of the larynx and hypopharynx: the IARC multi-center study in southwestern Europe.
Cancer Causes Control.
1996;7:240 - 252.
Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study.
Am J Clin Nutr. 1995;62(suppl):1427S - 1430S.
Chen J, Geissler C, Parpia B, et al. Antioxidant status and cancer mortality in China.
Int J Epidemiol.
1992;21:625 - 635.
White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer.
Cancer Epidemiol Biomarkers Prev. 1997;6:769 - 774.
Macready N. Vitamins associated with lower colon-cancer risk.
Lancet.
1997;350:1452.
Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly.
Am J Clin Nutr. 1996;64:190 - 196.
Bostick RM, Potter JD, McKenzie DR, et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study.
Cancer Res.
1993;53:4230 - 4237.
Ocke MC, Bueno-de-Mesquita H, Feskens EJ, et al. Repeated measurements of vegetables, fruits, beta-carotene, and vitamins C and E in relation to lung cancer. The Zutphen Study.
Am J Epidemiol.
1997;145:358 - 365.
Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.
Ann Intern Med.
1998;129:517 - 524.
Malila N, Virtamo J, Virtanen M, et al. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers.
Cancer Epidemiol Biomarkers Prev.
1999;8:489 - 493.
Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
N Engl J Med.
1996;334:1145 - 1149.
Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group.
N Engl J Med.
1994;331:141 - 147.
Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators.
N Engl J Med.
2000;342:154 - 160.
Lonn EM, Yusuf S, Dzavik V, et al. Effects of Ramipril and vitamin E on atherosclerosis. The study to evaluate carotid ultrasound changes in patients treated with Ramipril and vitamin E (SECURE).
Circulation. 2001;103:919 - 925.
Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice.
Lancet. 2001;357:89 - 95.
Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infraction.
Lancet. 1997;349:1715 - 1720.
Rapola JM, Virtamo J, Haukka JK, et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial.
JAMA.
1996;275:693 - 698.
Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study.
Am J Clin Nutr. 1995;62(suppl):1427S - 1430S.
Tornwall ME, Virtamo J, Haukka JK, et al. Alpha-tocopherol (vitamin E) and beta-carotene supplementation does not affect the risk for large abdominal aortic aneurysm in a controlled trial.
Atherosclerosis. 2001;157:167 - 173.
Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study.
Lancet. 1996;347:781 - 786.
Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men.
N Engl J Med. 1993;328:1450 - 1456.
Manson JE, Stampfer MJ, Willitt WC, et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women [abstract].
J Am Coll Nutr.
1992;11:609.
Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women.
N Engl J Med. 1993;328:1444 - 1449.
Bazzano LA, He J, Ogden LG, et al. Dietary vitamin E intake and risk of coronary heart disease in a representative sample of US adults: NHANES I Epidemiologic Follow-up Study [abstract].
Circulation. 2001;103:1366.
Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly.
Am J Clin Nutr. 1996;64:190 - 196.
Meagher EA, Barry OP, Lawson JA, et al. Effects of vitamin E on lipid peroxidation in healthy persons.
JAMA. 2001;285:1178 - 1182.
Christen S, Woodall AA, Shigenaga MK, et al. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications.
Proc Natl Acad Sci U S A. 1997;94:3217 - 3222.
Rimm EB, Ascherio A, Giovannucci E, et al. A prospective study of vitamin E and coronary heart disease among men: is benefit restricted only to primary prevention [abstract].
Circulation. 2001;103:1347.
Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial.
Lancet.
1999;354:810 - 816.
Elkashef AM, Wyatt RJ. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.
Schizophr Bull.
1999;25:731 - 740.
Adler LA, Edson R, Lavori P, et al. Long-term treatment effects of vitamin E for tardive dyskinesia.
Biol Psychiatry.
1998;43:868 - 872.
Adler LA, Edson R, Lavori P, et al. Long-term treatment effects of vitamin E for tardive dyskinesia.
Biol Psychiatry.
1998;43:868 - 872.
Elkashef AM, Wyatt RJ. Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.
Schizophr Bull.
1999;25:731 - 740.
Shriqui CL, Bradwejn J, Annable L, et al. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
Am J Psychiatry.
1992;149:391 - 393.
Soares, KV, BcGrath JJ. The treatment of tardive dyskinesia - a systematic review and meta-analysis.
Schizophr Res. 1999;39:1 - 16.
Rotrosen, J, Adler L, Lohr J, et al. Antioxidant treatment of tardive dyskinesia.
Prostaglandins Leukot Essent Fatty Acids. 1996;55:77 - 81.
Adler LA, Rotrosen J, Edson R, et al. Vitamin E treatment for tardive dyskinesia.
Arch Gen Psychiatry.
1999;56:836 - 841.
Adler LA, Rotrosen J, Edson R, et al. Vitamin E treatment for tardive dyskinesia.
Arch Gen Psychiatry.
1999;56:836 - 841.
Lohr JB, Lavori P. Whither vitamin E and tardive dyskinesia? [editorial]
Biol Psychiatry.
1998;43:861 - 862.
Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.
JAMA. 1997;277:1380 - 1386.
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease.
N Engl J Med. 1997;336:1216 - 1222.
Suleiman SA, Ali ME, Zaki ZM, et al. Lipid peroxidation and human sperm motility: protective role of vitamin E.
J Androl. 1996;17:530 - 537.
Rolf C, Cooper TG, Yeung CH, et al. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study.
Hum Reprod.
1999;14:1028 - 1033.
Manzella D, Barbieri M, Ragno E, et al. Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes.
Am J Clin Nutr. 2001;73:1052 - 1057.
National Academies. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes (DRIs) for Vitamins C and E, Selenium and Carotenoids. Available at:
http://www4.nationalacademies.org/IOM/IOMHome.nsf/Pages/Food+...+Nutrition+Board. Accessed January 16, 2001.
Leppala JM, Virtamo J, Fogelholm R, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers.
Arterioscler Thromb Vasc Biol.
2000;20:230 - 235.
Leppala JM, Virtamo J, Fogelholm R, et al. Vitamin E and beta carotene supplementation in high risk for stroke. A subgroup analysis of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study.
Arch Neurol. 2000;57:1503 - 1509.
Liede KE, Haukka JK, Saxen LM, et al. Increased tendency towards gingival bleeding caused by joint effect of alpha-tocopherol supplementation and acetylsalicylic acid.
Ann Med.
1998;30:542 - 546.
Kim JM, White RH. Effect of vitamin E on the anticoagulant response to warfarin.
Am J Cardiol. 1996;77:545 - 546.
Paolisso G, D'Amore A, Giugliano D, et al. Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients.
Am J Clin Nutr. 1993;57:650 - 656.
Paolisso G, D'Amore A, Galzerano D, et al. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients.
Diabetes Care. 1993;16:1433 - 1437.
Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy.
Oncology.
1999;13:1003 - 1012.
Weijl NI, Cleton FJ, Osanto S. Free radicals and antioxidants in chemotherapy-induced toxicity.
Cancer Treat Rev.
1997;23:209 - 240.
Desnuelle C, Dib M, Garrel C, et al. A double-blind, placebo-controlled randomized clinical trial of alpha-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis. ALS riluzole-tocopherol Study Group.
Amyotroph Lateral Scler Other Motor Neuron Disord.
2001;2:9 - 18.
Brand C, Snaddon J, Bailey M, et al. Vitamin E is ineffective for symptomatic relief of knee osteoarthritis: a six month double blind, randomised, placebo controlled study.
Ann Rheum Dis. 2001;60:946-949.
Ziaei S, Faghihzadeh S, Sohrabvand F, et al. A randomized, placebo-controlled trial to determine the effect of vitamin E in treatment of primary dysmenorrhoea.
BJOG.
2001;108:1181 - 1183.
Ohrvall M, Sundlof G, Vessby B. Gamma- but not alpha-tocopherol levels in serum are reduced in coronary heart disease patients.
J Intern Med.
1996;239:111-117.
Kristenson M, Zieden B, Kucinskiene Z, et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross-sectional study of men aged 50.
BMJ.
1997;314:629-633.
Kontush A, Spranger T, Reich A, et al. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol.
Atherosclerosis.
1999;144:117-122.
El-Sohemy A, Baylin A, Spiegelman D, et al. Dietary and adipose tissue gamma-tocopherol and risk of myocardial infarction.
Epidemiology.
2002;13:216 - 223.
Woodson K, Tangrea JA, Barrett MJ, et al. Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers.
J Natl Cancer Inst.
1999;91:1738-1743
Omenn GS. Micronutrients (vitamins and minerals) as cancer-preventive agents.
IARC Sci Publ.
1996;139:33-45.
[No authors listed]. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Lancet.
2002;360:23-33.
Helmy M, Shohayeb M, Helmy MH, et al. Antioxidants as adjuvant therapy in rheumatoid disease.
Arzneimittelforschung.
2001;51:293-298.
Kolarz G, Scherak O, El Shohoumi M, Blankenhorn G. High dose vitamin E for chronic arthritis.
Akt Rheumatol
1990;15:233-237.
Scherak O, Kolarz G. Vitamin E and rheumatoid arthritis.
Arthrit Rheum.
1991;34:1205 - 1206.
Muntwyler J, Hennekens CH, Manson JE, et al. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality.
Arch Intern Med.
2002;162:1472-1476.
Marchioli R, Schweiger C, Levantesi G, et al. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data.
Lipids.
2001;36:S53-63.
129 [No authors listed]. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Lancet.
2002;360:23-33.
Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
N Engl J Med.
2001;345:1583-1592.
Jiang Q, Christen S, Shigenaga MK, Ames BN. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.
Am J Clin Nutr.
2001;74:714-722.
Hodis HN, Mack WJ, LaBree L, et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).
Circulation. 2002;106:1453-1459.
Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial.
JAMA. 2002;288:715-21.
Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.
Diabetes Care. 2002;25:1919 - 1927.
Malila N, Taylor PR, Virtanen MJ, et al. Effects of alpha-tocopherol and beta-carotene supplementation on gastric cancer incidence in male smokers (ATBC Study, Finland).
Cancer Causes Control. 2002;13:617 - 623.
Virtamo J, Edwards BK, Virtanen M, et al. Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland).
Cancer Causes Control. 2000;11:933 - 939.
Ogunmekan AO, Hwang PA. A randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children.
Epilepsia
1989;30:84 - 89.
Raju GB, Behari M, Prasad K, et al. Randomized, double-blind, placebo-controlled, clinical trial of D-alpha-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy.
Epilepsia. 1994;35:368 - 372.
Levy SL, Burnham WM, Bishai A, et al. The anticonvulsant effects of vitamin E: a further evaluation.
Can J Neurol Sci. 1992;19:201 - 203.
Hom AC, Weaver RC, Aldersen JJ. Efficacy of D-alpha tocopherol acetate as adjunctive antiepileptic agent in patients with refractory epilepsy and profound developmental disability. A prospective, randomized, double-blind, placebo-controlled trial [abstract].
Epilepsia. 1991;32(Suppl 3):63.
Wluka AE, Stuckey S, Brand C, et al. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study.
J Rheumatol. 2002;29:2585 - 2591.
Taylor HR, Tikellis G, Robman LD, et al. Vitamin E supplementation and macular degeneration: randomised controlled trial.
BMJ. 2002;325:11.
Michaud DS, Pietinen P, Taylor PR, et al. Intakes of fruits and vegetables, carotenoids and vitamins A, E, C in relation to the risk of bladder cancer in the ATBC cohort study.
Br J Cancer. 2002;87:960 - 965.
Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy.
Gynecol Oncol. 2003;88:434 - 439.
Último revisado julio 2012 por EBSCO CAM Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.